Evidence map›Paper›PMID 32998074›Full record

ArticleProstaglandins & other lipid mediators2020

Improved quantification of lipid mediators in plasma and tissues by liquid chromatography tandem mass spectrometry demonstrates mouse strain specific differences.

Michael Armstrong, Jonathan Manke, Yasmeen Nkrumah-Elie, Saame Raza Shaikh, Nichole Reisdorph

Abstract read
In one paragraph

Article in Prostaglandins & other lipid mediators, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Altered tissue specialized pro-resolving mediators in chronic rhinosinusitis.Prostaglandins, leukotrienes, and essential fatty acids · 2021
    Trial
  3. Article
  4. Article
  5. Article
  6. Mast cells are key mediators in the pulmonary inflammatory response to formaldehyde exposure.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Michael ArmstrongUniversity of Colorado, Skaggs School of Pharmacy, 12850 E. Montview Blvd., Aurora, Colorado, United States.
Jonathan MankeUniversity of Colorado, Skaggs School of Pharmacy, 12850 E. Montview Blvd., Aurora, Colorado, United States.
Yasmeen Nkrumah-ElieChromadex Inc., Chromadex External Research Program (CERP), Longmont, Colorado, United States.
Saame Raza ShaikhDepartment of Nutrition, Gillings School of Global Public Health, The University of North Carolina, Chapel Hill, North Carolina, United States.
Nichole ReisdorphUniversity of Colorado, Skaggs School of Pharmacy, 12850 E. Montview Blvd., Aurora, Colorado, United States. Electronic address: NICHOLE.REISDORPH@CUANSCHUTZ.EDU.
University of Montana · USChromaDex (United States) · USUniversity of North Carolina at Chapel Hill · US

Funding

CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR025780 · NCRR · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2008 to 2011
$61.3M
Suppressing inflammation and boosting humoral immunity with n-3 PUFAsR01AT008375 · NCCIH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAIKH, SAAME R · 2015 to 2019
$1.9M
Improved Prediction of Response to Asthma Medication Using Small MoleculesR01HL123385 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI REISDORPH, NICHOLE A · 2014 to 2017
$1.8M
Sensitive Triple Quadrupole Mass Spectrometer for Translational ResearchS10OD010366 · OD · NATIONAL JEWISH HEALTH · PI REISDORPH, NICHOLE A · 2012 to 2012
$443k
NCCIH NIH HHS R01 AT008375NCRR NIH HHS UL1 RR025780NHLBI NIH HHS R01 HL123385NIH HHS S10 OD010366
6 · The paper itself

Abstract

A liquid chromatography tandem mass spectrometry-based method for the quantitation of 39 lipid mediators in four sample types and in two mouse strains is described. The method builds upon existing methodologies for analysis of lipid mediators by A) utilizing a bead homogenization step for tissue samples; this eliminates the need for homogenization glassware and improves homogenization consistency, B) optimizing the isolation and purification of lipid mediators with polymeric reverse phase SPE columns with lower sorbent masses; this results in lower solvent elution volumes without loss of recovery and C) utilizing an on-column enrichment method to improve analyte focusing before chromatographic separation. The method is linear from 0.25-250 pg on column for low level lipid mediators and from 5-5000 pg on column for high level lipid mediators. The addition of a methyl formate elution step to a previously published method dramatically improved precision and recovery for the cysteinyl leukotrienes. Accuracy and precision for 4 different sample types including human plasma, mouse lung, mouse spleen and mouse liver is demonstrated. Liver samples had extremely high levels of a tentatively identified bile acid which interfered with quantitation of resolvin E1, 11B-prostaglandin F2a and thromboxane A2. Results from 2 different tissue sources from untreated mice (C57BL/6 versus BALB/c) showed dramatically different concentrations of lipid mediators.

Indexed as

Tandem Mass SpectrometryAnimalsChromatography, LiquidHumansLipidsLiverLungMiceMice, Inbred C57BLSpecies SpecificitySpleenLipidsBALB/cbead millC57BL/6Lipid mediatorsmass spectrometrysolid phase extractiontissue homogenization

Identifiers

PMID32998074
PMCPMC13552491
OpenAlexW3090476062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.